Dabogratinib
5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-3-[6-(2-methylsulfonyl-2,6-diazaspiro[3.3]heptan-6-yl)-3-pyridinyl]-1H-indazole
Molecular Identity
Dabogratinib
5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-3-[6-(2-methylsulfonyl-2,6-diazaspiro[3.3]heptan-6-yl)-3-pyridinyl]-1H-indazole
PubChem CID: 170647464
2D Structure
Properties
C25H24Cl2N6O3S
Molecular Formula
559.50
Molecular Weight
g/mol
558.1008
Exact Mass
Da
3.6
XLogP
Drug-like (Lipinski: < 5)
113
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
916
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(19)
DabogratinibTYRA-3002800223-30-5A1AV2dabogratinib [INN]FH245S2JZJTYRA300orb2646016CHEMBL5595500SCHEMBL27188127SCHEMBL29712193GTPL13809EX-A9759compound 22 [PMID: 39258897]HY-159642
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Dabogratinib
Loading drug network...